Zealand Pharma A/S of Denmark has made an initial public offering of its shares on the Nasdaq OMX exchange in Copenhagen, one of the very few European biotechnology companies to seek a public listing in more than a year. ---Subscribe to MedNous to access this article--- Company News Finance, Grants, Deals
